Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-07-30

FDA Approved: BROMOCRIPTINE MESYLATE — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Zydus Pharmaceuticals USA Inc.'s generic bromocriptine mesylate product under an Original Application (ANDA). Bromocriptine mesylate is a dopamine …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bromocriptine mesylate (bromocriptine mesylate)

Snippet

ORIG AP for BROMOCRIPTINE MESYLATE (BROMOCRIPTINE MESYLATE)